A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance

about

A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance

Item

http://www.wikidata.org/entity/Q28553892

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@ast

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@en

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@nl

type

Item

label

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@ast

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@en

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@nl

prefLabel

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@ast

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@en

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@nl

P1476

A Cell-Based Assay for Measuri ...... ivity and Inhibitor Resistance

@en

P2093

Brett M Noel

http://www.w3.org/2001/XMLSchema#string

Steven B Ouellette

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline

Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

SRC kinase regulation in progressively invasive cancer

A multiple reaction monitoring (MRM) method to detect Bcr-Abl kinase activity in CML using a peptide biosensor

Targeting cancer with small molecule kinase inhibitors

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia

P304

e0161748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3667732

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0161748

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laurie L Parker

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27598410

http://www.w3.org/2001/XMLSchema#string

P932

5012566

http://www.w3.org/2001/XMLSchema#string